Skip to content

DRUG

BRIGHT MINDS BIOSCIENCES INC.

NASDAQ · Healthcare · Biotechnology · CA

$53.82
+4.91%
Ask drillr

Next report

Analyst consensus

Next report date
Dec 22, 2026
EPS estimate
-$1.15
Revenue estimate
—

Latest reported

Last report date
Aug 17, 2026
EPS actual
-$0.17
EPS estimate
-$1.22
Revenue actual
—
Revenue estimate
—

Track record

Trailing twelve quarters

EPS beats (12Q)
6
EPS misses (12Q)
0
EPS in line (12Q)
0
Avg surprise (4Q)
+46.9%
Revenue beats (12Q)
—

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$147
PT range
$145 – $150
Analysts
3
3 Buy0 Hold0 Sell
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 17, 2026-$1.22-$0.17Beat 86.10%—
May 20, 2026-$1.17-$0.80Beat 31.62%—
Feb 12, 2026-$0.98-$0.70Beat 28.57%—
Dec 23, 2025-$0.70-$0.41Beat 41.43%—
Aug 14, 2025-$0.59-$0.53Beat 10.17%—
Feb 13, 2025-$0.23$0.01Beat 104.35%—
Aug 14, 2024—$0.04——
May 15, 2024—-$0.10——
Aug 14, 2023—-$0.29——
May 15, 2023—-$0.08——
Feb 7, 2023—-$0.10——
Aug 12, 2022—-$0.87——

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 22, 2026